Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 1
1995 1
1999 1
2002 1
2003 1
2006 1
2007 1
2010 2
2012 1
2013 2
2014 2
2015 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis.
Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, Ueda A, Tada Y, Nakamura T, Kimoto Y, Mitoma H, Harashima S, Yoshizawa S, Shimoda T, Okamura S, Nagasawa K, Harada M. Horiuchi T, et al. Among authors: furugo i. Ann Rheum Dis. 2007 Mar;66(3):320-4. doi: 10.1136/ard.2006.058917. Epub 2006 Oct 6. Ann Rheum Dis. 2007. PMID: 17028114 Free PMC article. Review.
Urinary C4 excretion in systemic lupus erythematosus.
Ueda Y, Nagasawa K, Tsukamoto H, Horiuchi T, Yoshizawa S, Tsuru T, Furugo I, Niho Y. Ueda Y, et al. Among authors: furugo i. Clin Chim Acta. 1995 Dec 15;243(1):11-23. doi: 10.1016/0009-8981(95)06147-9. Clin Chim Acta. 1995. PMID: 8747510 Clinical Trial.
Systemic vasculitis associated with alphal-antitrypsin deficiency.
Takii Y, Inoue H, Karashima E, Akahoshi M, Furugo I, Hattori S, Yamanaka M, Kinoshita S, Hamasaki N, Shimoda K, Nakashima H, Tsukamoto H, Horiuchi T, Otsuka T, Harada M. Takii Y, et al. Among authors: furugo i. Intern Med. 2003 Jul;42(7):619-23. doi: 10.2169/internalmedicine.42.619. Intern Med. 2003. PMID: 12879958 Free article.
Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.
Kimoto Y, Horiuchi T, Tsukamoto H, Kiyohara C, Mitoma H, Uchino A, Furugo I, Yoshizawa S, Ueda A, Harashima S, Sawabe T, Tahira T, Hayashi K, Yoshizawa S, Shimoda T, Akashi K, Harada M. Kimoto Y, et al. Among authors: furugo i. Rheumatology (Oxford). 2010 Jul;49(7):1346-53. doi: 10.1093/rheumatology/keq050. Epub 2010 Apr 5. Rheumatology (Oxford). 2010. PMID: 20371502
Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T. Uchino A, et al. Among authors: furugo i. Clin Exp Rheumatol. 2010 Jan-Feb;28(1):6-12. Clin Exp Rheumatol. 2010. PMID: 20346231 Clinical Trial.
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
Hara M, Ishiguro N, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Yamamoto K; Iguratimod-Clinical Study Group. Hara M, et al. Mod Rheumatol. 2014 May;24(3):410-8. doi: 10.3109/14397595.2013.843756. Epub 2013 Nov 7. Mod Rheumatol. 2014. PMID: 24252050 Clinical Trial.
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.
Ishiguro N, Yamamoto K, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Hara M; Iguratimod-Clinical Study Group. Ishiguro N, et al. Mod Rheumatol. 2013 May;23(3):430-9. doi: 10.1007/s10165-012-0724-8. Epub 2012 Jul 26. Mod Rheumatol. 2013. PMID: 22833377 Clinical Trial.
15 results